Now available: Lindus Health's "All-In-One Metabolic CRO" to accelerate and streamline research in metabolic conditions such as diabetes, obesity, NASH, and more.

As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.

We're introducing our All-In-One CRO solution for the digital therapeutics market.

Robert Langer and Lindus Health co-founder, Meri Beckwith, sat down for a Q&A session to discuss their new partnership and future direction of the company.

We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.

In our latest fireside chat, we sat down with Dan Gusz, Chief of Staff at Signos, to discuss some of the common challenges sponsors see when collaborating with CROs along with the benefits of being cutting-edge in technology when approaching clinical trials.